Literature DB >> 22532683

Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKε.

Christelle Pythoud1, W W Shanaka I Rodrigo, Giulia Pasqual, Sylvia Rothenberger, Luis Martínez-Sobrido, Juan Carlos de la Torre, Stefan Kunz.   

Abstract

Arenaviruses perturb innate antiviral defense by blocking induction of type I interferon (IFN) production. Accordingly, the arenavirus nucleoprotein (NP) was shown to block activation and nuclear translocation of interferon regulatory factor 3 (IRF3) in response to virus infection. Here, we sought to identify cellular factors involved in innate antiviral signaling targeted by arenavirus NP. Consistent with previous studies, infection with the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV) prevented phosphorylation of IRF3 in response to infection with Sendai virus, a strong inducer of the retinoic acid-inducible gene I (RIG-I)/mitochondrial antiviral signaling (MAVS) pathway of innate antiviral signaling. Using a combination of coimmunoprecipitation and confocal microscopy, we found that LCMV NP associates with the IκB kinase (IKK)-related kinase IKKε but that, rather unexpectedly, LCMV NP did not bind to the closely related TANK-binding kinase 1 (TBK-1). The NP-IKKε interaction was highly conserved among arenaviruses from different clades. In LCMV-infected cells, IKKε colocalized with NP but not with MAVS located on the outer membrane of mitochondria. LCMV NP bound the kinase domain (KD) of IKKε (IKBKE) and blocked its autocatalytic activity and its ability to phosphorylate IRF3, without undergoing phosphorylation. Together, our data identify IKKε as a novel target of arenavirus NP. Engagement of NP seems to sequester IKKε in an inactive complex. Considering the important functions of IKKε in innate antiviral immunity and other cellular processes, the NP-IKKε interaction likely plays a crucial role in arenavirus-host interaction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22532683      PMCID: PMC3421673          DOI: 10.1128/JVI.00187-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

Review 1.  Biology and pathogenesis of lymphocytic choriomeningitis virus infection.

Authors:  M B A Oldstone
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

2.  VISA is an adapter protein required for virus-triggered IFN-beta signaling.

Authors:  Liang-Guo Xu; Yan-Yi Wang; Ke-Jun Han; Lian-Yun Li; Zhonghe Zhai; Hong-Bing Shu
Journal:  Mol Cell       Date:  2005-09-16       Impact factor: 17.970

Review 3.  Exotic emerging viral diseases: progress and challenges.

Authors:  Thomas W Geisbert; Peter B Jahrling
Journal:  Nat Med       Date:  2004-12       Impact factor: 53.440

4.  Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus.

Authors:  Luis Martínez-Sobrido; Elina I Zúñiga; Debralee Rosario; Adolfo García-Sastre; Juan Carlos de la Torre
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 5.  Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response.

Authors:  John Hiscott
Journal:  Cytokine Growth Factor Rev       Date:  2007-08-13       Impact factor: 7.638

6.  Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses.

Authors:  M J Buchmeier; H A Lewicki; O Tomori; M B Oldstone
Journal:  Virology       Date:  1981-08       Impact factor: 3.616

7.  Genetic dissection of interferon-antagonistic functions of rabies virus phosphoprotein: inhibition of interferon regulatory factor 3 activation is important for pathogenicity.

Authors:  Martina Rieder; Krzysztof Brzózka; Christian K Pfaller; James H Cox; Lothar Stitz; Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

Review 8.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

9.  Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation.

Authors:  Jessica E Hutti; Rhine R Shen; Derek W Abbott; Alicia Y Zhou; Kam M Sprott; John M Asara; William C Hahn; Lewis C Cantley
Journal:  Mol Cell       Date:  2009-05-14       Impact factor: 17.970

10.  Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction.

Authors:  Matthias Habjan; Ida Andersson; Jonas Klingström; Michael Schümann; Arnold Martin; Petra Zimmermann; Valentina Wagner; Andreas Pichlmair; Urs Schneider; Elke Mühlberger; Ali Mirazimi; Friedemann Weber
Journal:  PLoS One       Date:  2008-04-30       Impact factor: 3.240

View more
  78 in total

1.  Dengue virus subverts the interferon induction pathway via NS2B/3 protease-IκB kinase epsilon interaction.

Authors:  Yesseinia I Angleró-Rodríguez; Petraleigh Pantoja; Carlos A Sariol
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

2.  Toll-like receptor 2-mediated innate immune responses against Junín virus in mice lead to antiviral adaptive immune responses during systemic infection and do not affect viral replication in the brain.

Authors:  Christian D Cuevas; Susan R Ross
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

3.  Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man.

Authors:  Juan C Zapata; Maria S Salvato
Journal:  Future Virol       Date:  2015-03-13       Impact factor: 1.831

4.  Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.

Authors:  Benson Yee Hin Cheng; Emilio Ortiz-Riaño; Juan Carlos de la Torre; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

5.  Arenavirus nucleoproteins prevent activation of nuclear factor kappa B.

Authors:  W W Shanaka I Rodrigo; Emilio Ortiz-Riaño; Christelle Pythoud; Stefan Kunz; Juan C de la Torre; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

6.  Development of live-attenuated arenavirus vaccines based on codon deoptimization.

Authors:  Benson Yee Hin Cheng; Emilio Ortiz-Riaño; Aitor Nogales; Juan Carlos de la Torre; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

7.  Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein.

Authors:  Benson Y H Cheng; Aitor Nogales; Juan Carlos de la Torre; Luis Martínez-Sobrido
Journal:  Virology       Date:  2016-11-14       Impact factor: 3.616

8.  A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins.

Authors:  Xavier Carnec; Mathieu Mateo; Audrey Page; Stéphanie Reynard; Jimmy Hortion; Caroline Picard; Elsie Yekwa; Laura Barrot; Stéphane Barron; Audrey Vallve; Hervé Raoul; Caroline Carbonnelle; François Ferron; Sylvain Baize
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

9.  Identification of critical amino acids within the nucleoprotein of Tacaribe virus important for anti-interferon activity.

Authors:  Brooke Harmon; Carol Kozina; Dianna Maar; Timothy S Carpenter; Catherine S Branda; Oscar A Negrete; Bryan D Carson
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

10.  Activation of the RLR/MAVS Signaling Pathway by the L Protein of Mopeia Virus.

Authors:  Lei-Ke Zhang; Qi-Lin Xin; Sheng-Lin Zhu; Wei-Wei Wan; Wei Wang; Gengfu Xiao
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.